Using cBioportal and the The Cancer Genome Atlas’ (TCGA) PanCancer Atlas in our own analysis, we assessed 1082 breast cancer patients and grouped them into two categories based on TGF-β pathway gene expression (TGF-β high vs. low) [44,45,46,47]. The gene discussed is TGFB1; the disease is breast cancer.